10 articles
Body changes and sexual health on a GLP-1
Most of these questions have never been measured in a trial. Where they have not, these articles say so first, then set out what the labels, the weight-loss data, the case reports and the adverse-event databases do show, and which symptoms need a clinician rather than a search.
GLP-1 Side Effects in Women vs Men: What the Trials Measured
Women on Ozempic, Wegovy, Mounjaro and Zepbound report more nausea and hair loss and lose a larger share of their weight than men. The trial and label numbers by sex, why body size explains only part of it, and where the women- and men-specific questions are answered.
11 min read · 18 citationsOzempic Vulva: What the Evidence Shows About Fat Loss and the Labia
No GLP-1 trial or label has measured the vulva. The mons pubis and labia majora are mostly fat, and these drugs remove fat everywhere. What plastic surgeons see after large weight loss, and what fillers, fat grafting and surgery can and cannot do.
10 min read · 22 citationsOzempic and the Vagina: Dryness, Odor and Yeast Infections
No GLP-1 label lists a vaginal side effect. Genital yeast infections belong to SGLT2 diabetes drugs such as Jardiance, and GLP-1 users had fewer of them in cohort studies. What FDA reports show, likely causes of dryness and odor, and when to see a clinician.
11 min read · 20 citationsOzempic, Mounjaro and Your Period: Late, Heavy or Spotting on a GLP-1
No GLP-1 label lists period changes and no trial has measured them outside PCOS. What FDA adverse-event reports, the labels' rat data and the weight-loss evidence do show, why a late period means a pregnancy test first, and when bleeding needs a clinician.
10 min read · 22 citationsGLP-1 Drugs and Your Breasts: Size, Pain, Mammograms and Cancer Risk
No trial has measured breast changes on Ozempic, Wegovy, Mounjaro or Zepbound. What bariatric imaging studies show about breast volume, why no label lists breast pain, how weight loss alters mammogram density, and what randomized trials say about breast cancer.
10 min read · 19 citationsOzempic and Penis Size: What Weight Loss Changes and What It Does Not
No study has measured penile length on semaglutide or tirzepatide, and neither drug acts on penile tissue. Losing the fat pad over the pubic bone can expose more of the shaft. What the measured studies show, and when hidden length becomes buried penis.
9 min read · 21 citationsDoes Ozempic Cause Erectile Dysfunction? What the Evidence Shows
No GLP-1 label lists erectile dysfunction and no semaglutide or tirzepatide trial has measured erections. One database study found more ED after Ozempic; better-controlled studies and a dulaglutide trial did not. Plus Viagra and Cialis with a GLP-1.
12 min read · 29 citationsGLP-1s and Sex Drive: What Ozempic and Mounjaro Do to Libido in Men and Women
No large trial has measured whether Ozempic, Wegovy, Mounjaro or Zepbound lowers sex drive, and no US label mentions libido. What the one controlled trial, rodent studies, case reports and FDA adverse-event data show, and the ordinary causes to rule out first.
11 min read · 24 citationsOzempic Butt: What Large Weight Loss Changes in the Buttocks
No trial has measured buttock shape on semaglutide or tirzepatide. What changes is gluteal fat, some gluteal muscle and skin that does not retract, the same as with any large weight loss. What the DXA and MRI data show, what resistance training keeps, and what surgery can do.
11 min read · 21 citationsOzempic Feet and Hands: Swelling, Heel Pain, Tingling and Numbness
No trial has studied Ozempic and the feet. Swelling is not on any of eight GLP-1 labels, weight loss tends to ease heel pain, and the real concern is nerves: a labeled skin-sensation reaction and case reports of foot drop and neuropathy after fast weight loss.
12 min read · 25 citations